Use of Transplanted Regulatory T Cells Could Provide Relief for Inflammatory Diseases
Professor Juergen Hahn has received a $2 million NIH grant to investigate the use of transplanted regulatory T cells (Tregs) in reducing inflammation in diseases like inflammatory bowel disease, which currently has no known viable treatment options.